Forschungsprojekte
Ergebnisse pro Seite:
10
2018 - 2023
Exploring DNA methylation/gene silencing patterns in MDS/AML for potential therapeutic Targets- Dr. Borhane
2017 - 2019
AG-221 bei fortgeschrittener AML mit IDH2 Mutation in älteren Patienten (#623)- Prof. Dr. Markus
2017 - 2021
Proteine auf Nanocarriern: vom Stealth Effekt zu einem gezielten Targeting in vivo- Univ.-Prof. Dr. Stefan,
- Prof. Dr. Tanja,
- Prof. Dr. Volker
2017 - 2019
Impact of mutational pathways on immune environment, neoantigens and tumor rejection for the development of comprehensive biomarker panels in cancer immunotherapy- Prof. Dr. Angela,
- Prof. Dr. Stefan,
- Prof. Dr. Wilko,
- Prof. Dr. Hanno,
- Prof. Dr. Benedikt,
- Prof. Dr. Peter,
- Dr. Felix,
- Dr. Albrecht,
- Prof. Dr. Roland,
- Prof. Dr. Karsten,
- Prof. Dr. Marion,
- Prof. Dr. Christian,
- PD Dr. Thomas,
- Prof. Dr. Florian,
- Univ.-Prof. Dr. Thomas,
- Univ.-Prof. Dr. Matthias,
- Dr. Hakim,
- Prof. Dr. Sebastian,
- Jens,
- Prof. Dr. Nikolas,
- Dr. Melanie,
- Prof. Dr. Silke,
- Dr. Stefan,
- Prof. Dr. Martin,
- PD Dr. Gunnar,
- Prof. Dr. Evelin,
- Dr. Barbara,
- PD Dr. Anne,
- PD Dr. Sebastian,
- PD Dr. Frederick,
- Prof. Dr. Matthias,
- Prof. Dr. Jürgen
2017 - 2019
Chimeric antigen receptor-engineered natural killer cells as a universal cellular therapeutic for adoptive cancer immunotherapy (collaborative research project within translational immunotherapy program)- Prof. Dr. Winfried,
- Univ.-Prof. Dr. Matthias,
- Prof. Dr. Michael,
- Prof. Dr. Achim,
- Prof. Dr. Torsten,
- Prof. Dr. Dirk,
- PD Dr. Jessica,
- Prof. Dr. Jürgen,
- PD Dr. Annette